What is iRespond?
Founded in 2010, iRespond operates as an international non-profit dedicated to improving the quality of life globally through technology. Its core offering, the IRIS software application platform, is a secure, encrypted health-care data collection system that utilizes specialized biometric technologies. This system is particularly designed for isolated locations, providing secure patient databases and enabling access to health records comparable to larger hospitals. iRespond fosters a collaborative network, allowing global government and non-government organizations to safely exchange information via secure, local cloud-based servers, thereby increasing availability, reach, and efficiency in healthcare delivery. The organization actively builds partnerships with support and government entities, foundations, and local community groups, alongside forming unique agreements with the private sector to ensure its technologies are accessible where needed.
How much funding has iRespond raised?
iRespond has raised a total of $70K across 1 funding round:
Debt
$70K
Debt (2021): $70K with participation from PPP
Key Investors in iRespond
PPP
Public-Private Partnership
What's next for iRespond?
With significant Series B/C stage funding and recent substantial expansion capital, iRespond is poised for accelerated growth and broader implementation of its IRIS software. The company's strategic focus on partnerships and private sector agreements suggests a trajectory aimed at scaling its operations and enhancing its technological infrastructure. Future developments will likely involve expanding its reach to more remote and underserved regions, further solidifying its role as a critical provider of secure health-care data solutions in challenging environments. The organization's commitment to collaboration indicates a continued emphasis on building a robust ecosystem for global health-tech innovation.
See full iRespond company page
